Concepedia

Zehan Chen

ZC

Statistics

Publications

26

Citations

1.6K

H-Index

18

Active since

1998

Affiliations

Abbott Fund(Current)

Abbott (United States)

Abbott (United Kingdom)

Discovery Laboratories (United States)

Zehan Chen is an author at Abbott Fund specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1998–2022

26

Publications

26

Chk1 Mediates S and G2 Arrests through Cdc25A Degradation in Response to DNA-damaging Agents

Zhan Xiao, Zehan Chen, Angelo Gunasekera et al. · Journal of Biological Chemistry · 2003 · 382 citations · Full text

, , +17

NMR structure and mutagenesis of the FADD (Mort1) death-effector domain

Matthias Eberstadt, Baohua Huang, Zehan Chen et al. · Nature · 1998 · 240 citations

, , +10

Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics

Zehan Chen, Zhan Xiao, Wen‐Zhen Gu et al. · International Journal of Cancer · 2006 · 129 citations · Full text

, , +17

1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) Induces Phosphorylation of Eukaryotic Elongation Factor-2 (eEF2)

Zehan Chen, Sujatha M. Gopalakrishnan, Mai-Ha Bui et al. · Journal of Biological Chemistry · 2011 · 118 citations · Full text

, , +9

Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint.

Zehan Chen, Zhan Xiao, Jun Chen et al. · PubMed · 2003 · 92 citations

, , +17

1–5 of 26